Evidence map›Paper›PMID 32039843›Full record

ArticleJournal of Alzheimer's disease : JAD2020

Alcohol Consumption, Brain Amyloid-β Deposition, and Brain Structural Integrity Among Older Adults Free of Dementia.

Manja Koch, Simona Costanzo, Annette L Fitzpatrick, Oscar L Lopez, Steven DeKosky, Lewis H Kuller, Julie Price, Rachel H Mackey, Majken K Jensen, Kenneth J Mukamal

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Alcohol Use Disorder and Dementia: A Review.Alcohol research : current reviews · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Manja KochDepartment of NutritionHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Simona CostanzoDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli (IS), Italy.
Annette L FitzpatrickDepartments of Family Medicine, Epidemiology, and Global Health, University of Washington, Seattle, WA, USA.
Oscar L LopezDepartment of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Steven DeKoskyDepartment of Neurology, University of Florida, Gainesville, FL, USA.
Lewis H KullerDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Julie PriceDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Rachel H MackeyDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Majken K JensenDepartment of NutritionHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Kenneth J MukamalDepartment of NutritionHarvard T.H. Chan School of Public Health, Boston, MA, USA.
University of Pittsburgh · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USHarvard University · USIstituto Neurologico Mediterraneo · ITMassachusetts General Hospital · USUniversity of Florida · USUniversity of Washington · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMBOH, M. ILYAS · 1985 to 2019
$43.0M
GINKGO BILOBA PREVENTION TRIAL IN OLDER INDIVIDUALSU01AT000162 · NCCIH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOPEZ, OSCAR L. · 1999 to 2009
$34.7M
Novel lipoprotein particles, brain abnormalities, and risk of dementia and strokeR01NS089638 · NINDS · HARVARD SCHOOL OF PUBLIC HEALTH · PI JENSEN, MAJKEN KAROLINE · 2015 to 2018
$2.6M
NCCIH NIH HHS U01 AT000162NIA NIH HHS P50 AG005133NIA NIH HHS U24 AG021886NINDS NIH HHS R01 NS089638
6 · The paper itself

Abstract

backgroundLight to moderate alcohol consumption has been variably associated with lower or higher risk of dementia, but effects on Alzheimer's disease pathology are less clear.

objectiveWe determined whether late-life alcohol consumption was associated with Alzheimer's disease pathology among older adults.

methodsWe assessed the associations of alcohol consumption self-reported in 2000-2002 with brain amyloid-β deposition on PET scans, and white matter lesion and hippocampal volume on MRIs measured 7-9 years later in 189 participants of the Ginkgo Evaluation of Memory Study (age 75-87 years at baseline) who were free of clinical dementia, using multivariable-adjusted and inverse probability-weighted robust linear regression models.

resultsAlcohol consumption was not statistically significantly associated with amyloid-β deposition (standardized uptake value ratio difference per drink: -0.013 [95% CI: -0.027, 0.002]). Both non-drinkers and participants consuming ≥1 drink(s)/week had higher white matter lesion volume (% intracranial volume) than did the reference group of those consuming <1 drink/week (differences: 0.25 % [95% CI: 0.01, 0.50]; 0.26 % [95% CI: 0.02, 0.50]). The association of alcohol consumption and hippocampal volume was modified by age (p = 0.02). Among participants younger than 77 years, participants consuming 1-7 drinks/week had larger hippocampal volume compared with participants consuming <1 drink/week.

conclusionsAlcohol consumption was not statistically significantly associated with amyloid-β deposition 7-9 years later. Non-drinking and greater alcohol consumption were associated with higher white matter lesion volume compared with drinking <1 drink/week. Moderate drinking was associated with higher hippocampal volume in younger individuals. Given the selective nature of this population and adverse health effects of excessive alcohol consumption, these findings warrant further investigation, but cannot be translated into clinical recommendations.

Indexed as

Alcohol DrinkingBrain ChemistryAgedAged, 80 and overAmyloid beta-PeptidesBrainDementiaFemaleHippocampusHumansMagnetic Resonance ImagingMaleMemoryNeuroimagingPositron-Emission TomographySelf ReportAmyloid beta-PeptidesAlcoholbrain amyloid-βepidemiologyhippocampal volumewhite matter lesions

Identifiers

PMID32039843
PMCPMC7385407
OpenAlexW3005009974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.